|
|
Volumn 31, Issue 4, 2001, Pages 251-256
|
|
Thallium bone imaging as an indicator of response and outcome in nonmetastatic primary extremity osteosarcoma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
DOXORUBICIN;
IFOSFAMIDE;
METHOTREXATE;
THALLIUM 201;
ADOLESCENT;
ADULT;
ARTICLE;
BONE BIOPSY;
BONE RADIOGRAPHY;
BONE SCINTISCANNING;
BONE TUMOR;
CANCER ADJUVANT THERAPY;
CANCER SURVIVAL;
CAUCASIAN;
CHILD;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HISTOLOGY;
HUMAN;
IMAGE ANALYSIS;
LIMB TUMOR;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OBSERVER VARIATION;
OSTEOSARCOMA;
PREDICTION;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TUMOR DIFFERENTIATION;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
COMBINED MODALITY THERAPY;
EXTREMITIES;
FEMALE;
HUMANS;
MALE;
OBSERVER VARIATION;
OSTEOSARCOMA;
SURVIVAL ANALYSIS;
THALLIUM RADIOISOTOPES;
TREATMENT OUTCOME;
|
|
EID: 0035065718
PISSN: 03010449
EISSN: None
Source Type: Journal
DOI: 10.1007/s002470000405 Document Type: Article |
|
Times cited : (14)
|
|
References (30)
|
